Rasalect 0.5 Tablet (Rasagiline 0.5mg)

What is Rasalect 0.5 Tablet (Rasagiline 0.5mg)?

Rasalect 0.5 Tablet contains 0.5mg of rasagiline, a selective monoamine oxidase-B (MAO-B) inhibitor. It is prescribed to treat symptoms of Parkinson's disease by helping to restore dopamine balance in the brain. This medication is used either as monotherapy in early-stage Parkinson's or as an add-on treatment in more advanced cases. Rasalect helps improve motor control and reduce 'off' periods when symptoms are less controlled.

Key features

• Active Ingredient — Contains rasagiline 0.5mg, a potent MAO-B inhibitor.
• Dosage Strength — Low-dose formulation suitable for initial therapy.
• Once-Daily Dosing — Convenient single tablet per day improves adherence.
• Prescription Required — Available only with a valid medical prescription.
• Brand Quality — Manufactured under strict pharmaceutical standards.
• Stable Formulation — Designed for consistent absorption and efficacy.
• Parkinson's Support — Helps extend symptom relief between levodopa doses.

Who is Rasalect 0.5 Tablet (Rasagiline 0.5mg) for?

This medication is intended for adults diagnosed with Parkinson's disease, particularly those experiencing motor fluctuations. It may be prescribed to newly diagnosed patients or those already on levodopa who have 'off' episodes. It is not suitable for individuals with severe liver impairment or those taking certain antidepressants or other MAO inhibitors.

How does Rasalect 0.5 Tablet (Rasagiline 0.5mg) compare?

Compared to standard Parkinson’s medications like levodopa, Rasalect offers smoother symptom control with less risk of motor complications over time. It differs from other MAO-B inhibitors like selegiline by having a simpler metabolic profile and fewer dietary restrictions. While not a replacement for dopamine precursors, it enhances their effectiveness and delays the need for higher doses in early disease stages.